AI assistant
Sending…
ProPhase Labs, Inc. — Director's Dealing 2023
Jun 21, 2023
34999_dirs_2023-06-21_c91b01df-1fca-46dc-95c5-fd6103ae7676.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2023-06-19
Reporting Person: Hirsch Warren (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-06-19 | Option (right to buy) | $7.31 | A | 40000 | Acquired | 2023-06-18 | Common Stock (40000) | Direct |
Footnotes
F1: The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 19, 2023.
More from ProPhase Labs, Inc.
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Jan 27
Regulatory Filings
2026
Jan 23
Delisting Announcement
2026
Jan 23
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 2